RhoD participates in the regulation of cell-cycle progression and centrosome duplication

Oncogene

Volumn 32, Issue 14, 2013, Pages 1831-1842

  Kyrkou, A ^a,b   Soufi, M ^a   Bahtz, R ^c   Ferguson, C ^d   Bai, M ^a   Parton, R G ^d   Hoffmann, I ^c   Zerial, M ^e   Fotsis, T ^a,b   Murphy, C ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b INSTITUTE OF COMPUTER SCIENCE   (Greece)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

Author keywords

centrosome cycle; proliferation; RhoD

Indexed keywords

APHIDICOLIN; PROTEIN P53; RHO FACTOR; RHOD PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; CENTRIOLE; CENTROSOME; EPIDERMIS; G1 PHASE CELL CYCLE CHECKPOINT; GAIN OF FUNCTION MUTATION; HUMAN; HUMAN CELL; HYPERPLASIA; IN VITRO STUDY; LOSS OF FUNCTION MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BONE NEOPLASMS; CELL PROLIFERATION; CELLS, CULTURED; CENTROSOME; FLUORESCENT ANTIBODY TECHNIQUE; G1 PHASE; HUMANS; HYPERPLASIA; MICE; MICE, TRANSGENIC; MUTATION; OSTEOSARCOMA; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHO GTP-BINDING PROTEINS; RNA, MESSENGER; S PHASE; SKIN; TUMOR SUPPRESSOR PROTEIN P53; TWO-HYBRID SYSTEM TECHNIQUES;

MUS MUSCULUS;

EID: 84876104084     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.195     Document Type: Article

References (47)

1. Jaffe AB, Hall A. Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 2005; 21: 247-269.
2. Sit ST, Manser E. Rho GTPases and their role in organizing the actin cytoskeleton. J Cell Sci 2011; 124(Part 5): 679-683.
3. Nagasaki T, Gundersen GG. Depletion of lysophosphatidic acid triggers a loss of oriented detyrosinated microtubules in motile fibroblasts. J Cell Sci 1996; 109: 2461-2469.
4. Cook TA, Nagasaki T, Gundersen GG. Rho guanosine triphosphatase mediates the selective stabilization of microtubules induced by lysophosphatidic acid. J Cell Biol 1998; 141: 175-185.
5. Palazzo AF, Cook TA, Alberts AS, Gundersen GG. mDia mediates Rho-regulated formation and orientation of stable microtubules. Nat Cell Biol 2001; 3: 723-729.
6. Wen Y, Eng CH, Schmoranzer J, Cabrera-Poch N, Morris EJ, Chen M et al. EB1 and APC bind to mDia to stabilize microtubules downstream of Rho and promote cell migration. Nat Cell Biol 2004; 6: 820-830.
7. Mammoto A, Huang S, Moore K, Oh P, Ingber DE. Role of RhoA, mDia, and ROCK in cell shape-dependent control of the Skp2-p27kip1 pathway and the G1/S transition. J Biol Chem 2004; 279: 26323-26330.
8. Carreira S, Goodall J, Denat L, Rodriguez M, Nuciforo P, Hoek KS et al. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev 2006; 20: 3426-3439.
9. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev 2003; 3: 11-22.
10. Sahai E, Marshall CJ. RHO-GTPases and cancer. Nat Rev 2002; 2: 133-142.
11. Preudhomme C, Roumier C, Hildebrand MP, Dallery-Prudhomme E, Lantoine D, Lai JL et al. Nonrandom 4p13 rearrangements of the RhoH/TTF gene, encoding a GTP-binding protein, in non-Hodgkin's lymphoma and multiple myeloma. Oncogene 2000; 19: 2023-2032.
12. Schnelzer A, Prechtel D, Knaus U, Dehne K, Gerhard M, Graeff H et al. Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 2000; 19: 3013-3020.
13. Singh A, Karnoub AE, Palmby TR, Lengyel E, Sondek J, Rac1b Der CJ. a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation. Oncogene 2004; 23: 9369-9380.
14. Murphy C, Saffrich R, Grummt M, Gournier H, Rybin V, Rubino M et al. Endosome dynamics regulated by a Rho protein. Nature 1996; 384: 427-432.
15. Murphy C, Saffrich R, Olivo-Marin J-C, Giner A, Ansorge W, Fotsis T et al. Dual function of rhoD in vesicular movement and cell motility. Eur J Cell Biol 2001; 80: 391-398.
16. Tsubakimoto K, Matsumoto K, Abe H, Ishii J, Amano M, Kaibuchi K et al. Small GTPase RhoD suppresses cell migration and cytokinesis. Oncogene 1999; 18: 2431-2440.
17. Gasman S, Kalaidzidis Y, Zerial M. RhoD regulates endosome dynamics through Diaphanous-related formin and Src tyrosine kinase. Nat Cell Biol 2003; 5: 195-204.
18. Zanata SM, Hovatta I, Rohm B, Puschel AW. Antagonistic effects of Rnd1 and RhoD GTPases regulate receptor activity in Semaphorin 3A-induced cytoskeletal collapse. J Neurosci 2002; 22: 471-477.
19. Tong Y, Chugha P, Hota PK, Alviani RS, Li M, Tempel W et al. Binding of Rac1, Rnd1, and RhoD to a novel Rho GTPase interaction motif destabilizes dimerization of the plexin-B1 effector domain. J Biol Chem 2007; 282: 37215-37224.
20. Moll R, Franke W, Schiller D, Geiger B, Krepler R. The catalogue of human cyto-keratins: patterns of expression in nromal epithelia, tumors and cancer cells. Cell 1982; 31: 11-24.
21. Stoler A, Kopan R, Duvic M, Fuchs E. Use of specific antibodies and cDNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation. J Cell Biol 1988; 107: 427-446.
22. Rain JC, Selig L, De Reuse H, Battaglia V, Reverdy C, Simon S et al. The protein-protein interaction map of Helicobacter pylori. Nature 2001; 409: 211-215.
23. Kato T, Watanabe N, Morishima Y, Fujita A, Ishizaki T, Narumiya S. Localization of a mammalian homolog of diaphanous, mDia1, to the mitotic spindle in HeLa cells. J Cell Sci 2000; 114: 775-784.
24. Kubo A, Tsukita S. Non-membranous granular organelle consisting of PCM-1: subcellular distribution and cell-cycle-dependent assembly/disassembly. J Cell Sci 2003; 116(Part 5): 919-928.
25. Balczon R, Bao L, Zimmer WE, Brown K, Zinkowski RP, Brinkley BR. Dissociation of centrosome replication events from cycles of DNA synthesis and mitotic division in hydroxyurea-arrested Chinese hamster ovary cells. J Cell Biol 1995; 130: 105-115.
26. Cizmecioglu O, Arnold M, Bahtz R, Settele F, Ehret L, Haselmann-Weiss U et al. Cep152 acts as a scaffold for recruitment of Plk4 and CPAP to the centrosome. J Cell Biol 2010; 191: 731-739.
27. Warnke S, Kemmler S, Hames RS, Tsai HL, Hoffmann-Rohrer U, Fry AM et al. Pololike kinase-2 is required for centriole duplication in mammalian cells. Curr Biol 2004; 14: 1200-1207.
28. Ma Z, Kanai M, Kawamura K, Kaibuchi K, Ye K, Fukasawa K. Interaction between ROCK II and nucleophosmin/B23 in the regulation of centrosome duplication. Mol Cell Biol 2006; 26: 9016-9034.
29. Hu W, Bellone CJ, Baldassare JJ. RhoA stimulates p27(Kip) degradation through its regulation of cyclin E/CDK2 activity. J Biol Chem 1999; 274: 3396-3401.
30. Yamamoto M, Marui N, Sakai T, Morii N, Kozaki S, Ikai K et al. ADP-ribosylation of the rhoA gene product by botulinum C3 exoenzyme causes Swiss 3T3 cells to accumulate in the G1 phase of the cell cycle. Oncogene 1993; 8: 1449-1455.
31. waf1/cip1. Nature 1998; 394: 295-299.
32. Villalonga P, Ridley AJ. Rho GTPases and cell cycle control. Growth Factors 2006; 24: 159-164.
33. Carrano AC, Eytan E, Hershko A, Pagano M. SKP2 is required for ubiquitin-medi-ated degradation of the CDK inhibitor p27. Nat Cell Biol 1999; 1: 193-199.
34. Lacey KR, Jackson PK, Stearns T. Cyclin-dependent kinase control of centrosome duplication. Proc Natl Acad SciUSA 1999; 96: 2817-2822.
35. Hinchcliffe EH, Li C, Thompson EA, Maller JL, Sluder G. Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. Science (New York, NY) 1999; 283: 851-854.
36. Okuda M, Horn HF, Tarapore P, Tokuyama Y, Smulian AG, Chan PK et al. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell 2000; 103: 127-140.
37. Tokuyama Y, Horn HF, Kawamura K, Tarapore P, Fukasawa K. Specific phosphorylation of nucleophosmin on Thr(199) by cyclin-dependent kinase 2-cyclin E and its role in centrosome duplication. J Biol Chem 2001; 276: 21529-21537.
38. Cizmecioglu O, Warnke S, Arnold M, Duensing S, Hoffmann I. Plk2 regulated centriole duplication is dependent on its localization to the centrioles and a functional polo-box domain. Cell Cycle 2008; 7: 3548-3555.
39. Krause A, Hoffmann I. Polo-like kinase 2-dependent phosphorylation of NPM/B23 on serine 4 triggers centriole duplication. PLoS One 2010; 5: e9849.
40. Habedanck R, Stierhof YD, Wilkinson CJ, Nigg EA. The Polo kinase Plk4 functions in centriole duplication. Nat Cell Biol 2005; 7: 1140-1146.
41. Kleylein-Sohn J, Westendorf J, Le Clech M, Habedanck R, Stierhof YD, Nigg EA. Plk4-induced centriole biogenesis in human cells. Dev Cell 2007; 13: 190-202.
42. Eckerdt F, Yamamoto TM, Lewellyn AL, Maller JL. Identification of a polo-like kinase 4-dependent pathway for de novo centriole formation. Curr Biol 2011; 21: 428-432.
43. Panopoulou E, Gillooly DJ, Wrana JL, Zerial M, Stenmark H, Murphy C et al. Early endosomal regulation of Smad-dependent signaling in endothelial cells. J Biol Chem 2002; 277: 18046-18052.
44. Bellou S, Hink MA, Bagli E, Panopoulou E, Bastiaens PI, Murphy C et al. VEGF autoregulates its proliferative and migratory ERK1/2 and p38 cascades by enhancing the expression of DUSP1 and DUSP5 phosphatases in endothelial cells. Am J Physiol Cell Physiol 2009; 297: C1477-C1489.
45. Panopoulou E, Murphy C, Rasmussen H, Bagli E, Rofstad EK, Fotsis T. Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and anti-angiogenic mechanisms. Cancer Res 2005; 65: 1877-1886.
46. Sflomos G, Kostaras E, Panopoulou E, Pappas N, Kyrkou A, Politou AS et al. ERBIN is a new SARA-interacting protein: competition between SARA and SMAD2 and SMAD3 for binding to ERBIN. J Cell Sci 2011; 124: 3209-3222.
47. Christoforidis S, Zerial M. Purification and identification of novel Rab effectors using affinity chromatography. Methods 2000; 20: 403-410.